Company Overview
Company Name
Trevi Therapeutics
Address
195 Church Street, New Haven, CT, 06510, United States
Website
trevitherapeutics.comPhone
(203) 304-2499Approx. Annual Revenue
$7.2M
Employees
40
Established
2011
Locations
2
About Trevi Therapeutics
Trevi Therapeutics is a biopharmaceutical company headquartered in New Haven, Connecticut, United States. The company is dedicated to developing haduvio (oral nalbuphine ER) to help patients with chronic cough conditions, which can have significant physical, psychological, and social impacts.
Recent changes
What changed on the Trevi Therapeutics website and Google listing, as detected by Coldlytics on each visit.
Google Ads pixel installed
Coldlytics tracks changes like these across millions of businesses, so you can reach companies the moment they add a pixel, start hiring, or switch software.
Find companies by what just changed →Trevi Therapeutics locations
2 Google Business Profile listings.
| Location | Google category | Reviews | Status |
|---|---|---|---|
| 195 Church Street, New Haven, CTprimary | — | — | — |
| 195 Church St, New Haven, CT | — | — | Claimed |
More Companies in Connecticut
Browse all companies in Connecticut →
Frequently Asked Questions about Trevi Therapeutics
Advertising Pixels
- Google Ad Pixel
Categories
Technologies Used
;%20fill-rule:%20evenodd;%20}%20.cls-2%20{%20fill:%20none;%20}%20%3c/style%3e%3clinearGradient%20id='linear-gradient'%20x1='-1275.62'%20y1='432.1'%20x2='-1272.18'%20y2='427.35'%20gradientTransform='translate(30659%2010381.36)%20scale(24%20-24)'%20gradientUnits='userSpaceOnUse'%3e%3cstop%20offset='0'%20stop-color='%2325c5ff'/%3e%3cstop%20offset='.45'%20stop-color='%230048ff'/%3e%3cstop%20offset='1'%20stop-color='%23c500f3'/%3e%3c/linearGradient%3e%3c/defs%3e%3cpath%20class='cls-2'%20d='M0,0H150V150H0V0Z'/%3e%3cg%20id='Layer_2'%20data-name='Layer%202'%3e%3cg%20id='Layer_1-2'%20data-name='Layer%201-2'%3e%3cg%20id='Artboard'%3e%3cg%20id='userway_logo'%20data-name='userway%20logo'%3e%3cpath%20id='Combined-Shape'%20class='cls-1'%20d='M18.75,36.94c5.16-.03,9.36,4.13,9.39,9.28,0,.03,0,.07,0,.1h0v7.3h0v23.47c0,26.79,21.71,48.5,48.5,48.5s48.5-21.71,48.5-48.5h0v-23.99h0v-7.3c-.03-5.16,4.13-9.36,9.28-9.39,.03,0,.07,0,.1,0h4.69v40.68c0,34.56-28.02,62.58-62.58,62.58S14.06,111.66,14.06,77.1h0V36.94h4.69Zm2.09-22.42c16.1-.03,29.18,13,29.2,29.1,0,.03,0,.07,0,.1v33.38c0,14.69,11.91,26.6,26.6,26.6s26.6-11.91,26.6-26.6V43.72c-.03-16.1,13-29.18,29.1-29.2,.03,0,.07,0,.1,0h6.78v14.08h-6.78c-8.35,0-15.12,6.77-15.12,15.12v33.38c0,22.18-17.98,40.16-40.16,40.16h0c-22.28,.03-40.42-17.88-40.68-40.16V43.72c-.08-8.44-6.99-15.21-15.43-15.13-.07,0-.14,0-.21,0h-6.78V14.52h6.78Z'/%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
Social Profiles
Key Decision Makers
Paula Buckley Vice President Clinical Operations